Please use this identifier to cite or link to this item:
https://www.arca.fiocruz.br/handle/icict/27668
FUNDING AND INNOVATION IN DISEASES OF NEGLECTED POPULATIONS: THE PARADOX OF CRYPTOCOCCAL MENINGITIS
Rodrigues, Marcio Lourenço | Date Issued:
2016
Author
Affilliation
Fundação Oswaldo Cruz. Centro de Desenvolvimento Tecnológico em Saúde. Rio de Janeiro, RJ, Brasil / Universidade Federal do Rio de Janeiro. Instituto de Microbiologia Paulo de Góes. Rio de Janeiro, RJ, Brasil.
Abstract
It is estimated that fungal infections cause 1 million deaths annually, accounting for 50% of all AIDS-related deaths. In this specific patient group, data from 2009 revealed that fungal meningitis is responsible for approximately 500,000 deaths each year. The most common fungal pathogen infecting the brain is Cryptococcus neoformans, a yeast-
like pathogen that is highly efficient in causing damage to immunosuppressed human hosts. The fungus, which is widespread in the environment, primarily reaches the lung after inhalation of environmental cells and disseminates to the brain in the immunosuppressed host. Clinical studies in humans in combination with animal models of neurological cryptococcosis enabled the classification of the disease into different syndromes, including meningitis, encephalitis, meningoencephalitis, ventriculitis, increased intracranial pressure, and space-occupying lesions. According to the Centers for Disease Control and Prevention (CDC) of the United States, cryptococcal meningitis is a global problem. Estimates by Park and colleagues indicated that approximately 957,900 cases (range, 371,700 – 1,544,000) of cryptococcal meningitis occur each year, resulting in 624,700 deaths (range, 125,000 – 1,124,900) by three months after infection. Currently, estimates of global disease burden, including disability-adjusted life year (DALY), are not available, since cryptococcosis is not separately reported. Most cases are opportunistic infections that occur among people with HIV/AIDS.
Share